Fort Pitt Capital Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$159M	Buy	256,315 +3,766	+1%	+$2.23M	4.46%	2
2024 Q2	$140M	Buy	252,549 +5,357	+2%	+$3.07M	4.24%	3
2024 Q1	$144M	Buy	247,192 +6,758	+3%	+$3.79M	4.43%	2
2023 Q4	$128M	Buy	240,434 +59,941	+33%	+$29M	4.19%	3
2023 Q3	$91.4M	Buy	180,493 +74,107	+70%	+$39.5M	3.43%	6
2023 Q2	$55.5M	Buy	106,386 +3,805	+4%	+$2.05M	2.04%	25
2023 Q1	$59.1M	Buy	102,581 +1,458	+1%	+$822K	2.28%	18
2022 Q4	$55.7M	Buy	101,123 +2,736	+3%	+$1.45M	2.27%	20
2022 Q3	$49.9M	Buy	98,387 +242	+0.2%	+$135K	2.29%	21
2022 Q2	$53.3M	Buy	98,145 +3,826	+4%	+$2.11M	2.32%	20
2022 Q1	$55.7M	Buy	94,319 +15,290	+19%	+$8.78M	2.08%	21
2021 Q4	$52.7M	Buy	79,029 +4,525	+6%	+$2.83M	1.91%	23
2021 Q3	$42.6M	Buy	74,504 +27,340	+58%	+$15M	1.77%	27
2021 Q2	$23.8M	Buy	47,164 +5,618	+14%	+$2.65M	0.97%	39
2021 Q1	$19M	Buy	41,546 +6,777	+19%	+$3.23M	0.85%	43
2020 Q4	$16.2M	Buy	34,769 +2,233	+7%	+$1.05M	0.78%	41
2020 Q3	$14.4M	Buy	32,536 +1,323	+4%	+$547K	0.8%	39
2020 Q2	$11.3M	Buy	31,213 +911	+3%	+$305K	0.67%	43
2020 Q1	$8.59M	Buy	30,302 +17,423	+135%	+$5.49M	0.59%	46
2019 Q4	$4.08M	Sell	12,879 -149	-1%	-$45.2K	0.23%	62
2019 Q3	$3.79M	Buy	+13,028	New	+$3.73M	0.23%	63